Table 3.
| Maternal serum PP13 concentrations adjusted to the linear regression model (pg/ml)1 | ||
|---|---|---|
| Gestational weeks | Control2 | Preeclampsia2 |
| 24 | 53.8 | NA |
| 25 | 58.5 | NA |
| 26 | 63.7 | NA |
| 27 | 69.3 | 239.9 |
| 28 | 75.4 | 235.4 |
| 29 | 82.0 | 230.9 |
| 30 | 89.2 | 226.6 |
| 31 | 97.1 | 222.3 |
| 32 | 105.6 | 218.2 |
| 33 | 114.9 | 214.1 |
| 34 | 125.0 | 210.0 |
| 35 | 136.0 | 206.1 |
| 36 | 148.0 | 202.2 |
| 37 | 161.0 | 198.4 |
| 38 | 175.1 | 194.7 |
| 39 | 190.6 | 191.0 |
| 40 | 207.3 | NA |
1
The equation of the linear model was used for the intrapolation of gestational age-specific maternal serum PP13 concentrations in control women and in patients with preeclampsia.
2
Each value represents an intersection on the regression lines for the given gestational week.